Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities
J Varga, M Trojanowska… - Journal of Scleroderma …, 2017 - journals.sagepub.com
Systemic sclerosis (SSc) is a complex disease characterized by early microvascular
abnormalities, immune dysregulation and chronic inflammation, and subsequent fibrosis of …
abnormalities, immune dysregulation and chronic inflammation, and subsequent fibrosis of …
The pathogenesis of systemic sclerosis: an understanding based on a common pathologic cascade across multiple organs and additional organ-specific pathologies
Y Asano - Journal of clinical medicine, 2020 - mdpi.com
Systemic sclerosis (SSc) is a multisystem autoimmune and vascular disease resulting in
fibrosis of various organs with unknown etiology. Accumulating evidence suggests that a …
fibrosis of various organs with unknown etiology. Accumulating evidence suggests that a …
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis
Objective Systemic sclerosis (SSc) features multiorgan fibrosis orchestrated predominantly
by activated myofibroblasts. Endothelial-to-mesenchymal transition (EndoMT) is a …
by activated myofibroblasts. Endothelial-to-mesenchymal transition (EndoMT) is a …
Vasculopathy in scleroderma
Y Asano, S Sato - Seminars in immunopathology, 2015 - Springer
Systemic sclerosis (SSc) is a multisystem connective tissue disorder featured by vascular
injury and fibrosis of the skin and various internal organs with autoimmune background …
injury and fibrosis of the skin and various internal organs with autoimmune background …
Systemic sclerosis
Y Asano - The Journal of dermatology, 2018 - Wiley Online Library
Systemic sclerosis (SS c) is a multisystem autoimmune disease characterized by
vasculopathy and tissue fibrosis of the skin and various internal organs. A series of genetic …
vasculopathy and tissue fibrosis of the skin and various internal organs. A series of genetic …
A potential link between oxidative stress and endothelial-to-mesenchymal transition in systemic sclerosis
Systemic sclerosis (SSc), an autoimmune disease that is associated with a number of
genetic and environmental risk factors, is characterized by progressive fibrosis and …
genetic and environmental risk factors, is characterized by progressive fibrosis and …
Systemic sclerosis pathogenesis and emerging therapies, beyond the fibroblast
A Sierra-Sepúlveda… - BioMed research …, 2019 - Wiley Online Library
Systemic sclerosis (SSc) is a complex rheumatologic autoimmune disease in which
inflammation, fibrosis, and vasculopathy share several pathogenic pathways that lead to …
inflammation, fibrosis, and vasculopathy share several pathogenic pathways that lead to …
Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis
B Korman - Translational Research, 2019 - Elsevier
Systemic sclerosis (SSc, scleroderma) is a complex multisystem disease characterized by
autoimmunity, vasculopathy, and most notably, fibrosis. Multiple lines of evidence …
autoimmunity, vasculopathy, and most notably, fibrosis. Multiple lines of evidence …
Endothelial-to-mesenchymal transition in systemic sclerosis
P Di Benedetto, P Ruscitti, O Berardicurti… - Clinical & …, 2021 - academic.oup.com
Systemic sclerosis (SSc) is an autoimmune disease characterized by significant vascular
alterations and multi-organ fibrosis. Microvascular alterations are the first event of SSc and …
alterations and multi-organ fibrosis. Microvascular alterations are the first event of SSc and …
Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: possible roles in scleroderma
T Takahashi, Y Asano, K Sugawara… - Journal of Experimental …, 2017 - rupress.org
Systemic sclerosis (SSc), or scleroderma, is a multisystem autoimmune disorder
characterized by vasculopathy and fibrosis in the skin and internal organs, most frequently in …
characterized by vasculopathy and fibrosis in the skin and internal organs, most frequently in …